BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23811250)

  • 1. Factors that affect life expectancy of patients with gastric adenocarcinoma.
    Chen WY; Cheng HC; Wang JD; Sheu BS
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1595-600. PubMed ID: 23811250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
    Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
    Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
    Chu PC; Wang JD; Hwang JS; Chang YY
    Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
    Chen PC; Lee JC; Wang JD
    PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
    Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of reduced life expectancy from serious occupational injuries in Taiwan.
    Ho JJ; Hwang JS; Wang JD
    Accid Anal Prev; 2006 Sep; 38(5):961-8. PubMed ID: 16712760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis on expected years of life lost due to pancreatic cancer.
    Cucchetti A; Ercolani G; Taffurelli G; Serenari M; Maroni L; Pezzilli R; Del Gaudio M; Ravaioli M; Cescon M; Pinna AD
    Pancreatology; 2016; 16(3):449-53. PubMed ID: 26951889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.
    Chang KC; Lu TH; Lee KY; Hwang JS; Cheng CM; Wang JD
    Drug Alcohol Depend; 2015 Aug; 153():152-8. PubMed ID: 26054944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative life expectancy in gastric cancer patients and its associated factors.
    Zeraati H; Mahmoudi M; Kazemnejad A; Mohammed K
    Saudi Med J; 2005 Aug; 26(8):1203-7. PubMed ID: 16127513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer: a case study in Turkey.
    Tural D; Selçukbiricik F; Akar E; Serdengeçti S; Büyükünal E
    J Cancer Res Ther; 2013; 9(4):644-8. PubMed ID: 24518710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach?
    Maeda H; Okabayashi T; Nishimori I; Sugimoto T; Namikawa T; Dabanaka K; Tsujii S; Onishi S; Kobayashi M; Hanazaki K
    J Am Coll Surg; 2008 Feb; 206(2):306-10. PubMed ID: 18222384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas.
    Whitson BA; Groth SS; Li Z; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):43-8. PubMed ID: 19660401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric adenocarcinoma in patients 40 years of age or younger.
    Theuer CP; de Virgilio C; Keese G; French S; Arnell T; Tolmos J; Klein S; Powers W; Oh T; Stabile BE
    Am J Surg; 1996 Nov; 172(5):473-6; discussion 476-7. PubMed ID: 8942547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-standardized expected years of life lost: quantification of cancer severity.
    Wang Y; Chiang CJ; Lee WC
    BMC Public Health; 2019 May; 19(1):486. PubMed ID: 31046731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
    Le A; Berger D; Lau M; El-Serag HB
    Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
    Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
    Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of bladder cancer in men and women: analysis of the years of life lost.
    Scosyrev E; Golijanin D; Wu G; Messing E
    BJU Int; 2012 Jan; 109(1):57-62. PubMed ID: 21883817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
    Al-Refaie WB; Tseng JF; Gay G; Patel-Parekh L; Mansfield PF; Pisters PW; Yao JC; Feig BW
    Cancer; 2008 Aug; 113(3):461-9. PubMed ID: 18553367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.